Literature DB >> 17457002

Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms do not affect early functional and structural changes in atherosclerosis: the Cardiovascular Risk in Young Finns study.

Tuomo Nieminen1, Mika Kähönen, Shaheenul Islam, Olli T Raitakari, Nina Hutri-Kähönen, Jukka Marniemi, Markus Juonala, Riikka Rontu, Jorma Viikari, Terho Lehtimäki.   

Abstract

BACKGROUND: The present study was designed to investigate the effects of apoB XbaI and apoA-I/C-III/A-IV SstI polymorphisms to carotid artery intima-media thickness (IMT), carotid artery compliance (CAC) and brachial artery flow-mediated vasodilatation (FMD). METHODS AND
RESULTS: As part of the Cardiovascular Risk in Young Finns Study, the carotid IMT, CAC and brachial FMD of 2,265 subjects (mean age +/- SD 32 +/-5 years) were measured with ultrasonography, and genotyping of the apolipoprotein polymorphisms was performed. The frequencies of the genotypes did not differ between the groups with high (above median 0.57 mm) and low (below median) IMT, CAC or FMD. The average carotid IMT differed between the 3 apoB XbaI genotypes (ANOVA, p=0.04), but not between the apoA-I/C-III/A-IV SstI genotypes (ANOVA, p=0.53). The relationship between the polymorphisms and carotid IMT was not significant in any of the covariate-adjusted logistic and linear regression analyses. CAC and FMD were not influenced by either of the polymorphisms in ANOVA and regression analyses.
CONCLUSIONS: The polymorphisms apoA-I/C-III/A-IV SstI and apoB XbaI do not seem to affect carotid artery characteristics or brachial artery FMD in young adulthood.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457002     DOI: 10.1253/circj.71.741

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran Lipid and Glucose Study.

Authors:  Maryam S Daneshpour; Bita Faam; Mohamad Ali Mansournia; Mehdi Hedayati; Sohrab Halalkhor; Seyed Alireza Mesbah-Namin; Shahla Shojaei; Maryam Zarkesh; Fereidoun Azizi
Journal:  Endocrine       Date:  2011-11-22       Impact factor: 3.633

2.  Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.

Authors:  Rui-Xing Yin; Yi-Yang Li; Chao-Qiang Lai
Journal:  Lipids Health Dis       Date:  2011-08-19       Impact factor: 3.876

3.  Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis.

Authors:  Yongyan Song; Liren Zhu; Mudwari Richa; Ping Li; Yang Yang; Suping Li
Journal:  Lipids Health Dis       Date:  2015-04-18       Impact factor: 3.876

4.  Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.

Authors:  Caiqin Niu; Zhi Luo; Liuqin Yu; Yang Yang; Yun Chen; Xin Luo; Feiya Lai; Yongyan Song
Journal:  Lipids Health Dis       Date:  2017-09-06       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.